Abraxis BioScience, Inc. (NASDAQ:APPX.DL)
CAPS Rating:
An integrated biopharmaceutical company which develops, manufactures and markets the portfolios of injectable products and leverage revolutionary technology.
An integrated biopharmaceutical company which develops, manufactures and markets the portfolios of injectable products and leverage revolutionary technology.